This content is machine translated Annual Congress of the American Urological Association (AUA), San Francisco Risk assessment in prostate cancer: what do biomarkers do? Since the implementation of PSA testing, the number of PCa diagnoses has multiplied. Biomarkers are increasingly used to prevent overdiagnosis and overtreatment. New approaches, but also limitations, of microbiological testing…
View Post 8 min This content is machine translated Drug therapy of prostate carcinoma Androgen deprivation remains therapy of choice The goal of drug therapy for prostate cancer (PCa) is to prolong survival with acceptable side effects. Today, several drugs are available to achieve effective androgen deprivation therapy (ADT). The…
View Post 7 min This content is machine translated Prostate Cancer Therapy Curative treatment of localized prostate carcinoma Today, 90% of prostate cancers are detected at the localized and thus potentially curable stage. Finding the optimal therapeutic strategy for localized carcinoma is challenging for physicians and patients. Active…
